New Delhi, Aug. 19 -- Lord's Mark Industries Limited, a diversified healthcare and technology company, today announced a series of strategic and business updates marking an expansion of its global healthcare platform alongside a proposed corporate restructuring of its renewable energy division.

For FY2027, the Company expects consolidated revenue of at least Rs.1,550 crore, representing over 20% growth compared to FY2026, and Profit After Tax (PAT) of at least Rs.178 crore at a margin of 11.4%, reflecting a margin expansion of over 200 basis points. The majority of FY2027 growth will be driven by core operations in in-vitro diagnostics and renewable energy, with further operational momentum expected from FY2028 onward through the commerc...